Attorneys General Bob Ferguson of Washington and Kamala Harris of California are the latest officials to take legal action against vaginal mesh, an implant often used to treat pelvic organ prolapse.
Vaginal mesh implants can present risks including urinary dysfunction, loss of sexual function, constipation and severe pain. Both suits claim Johnson & Johnson failed to disclose such risks to consumers. Specifically, California’s lawsuit alleges false advertising and deceptive marketing, while Washington’s lawsuit alleges violations of the state’s consumer protection law.
Amber and Steve Mostyn of Mostyn Law applaud Attorneys General Bob Ferguson and Kamala Harris for taking action on behalf of constituents.
“Companies must stop putting profits ahead of Americans’ health and be more forthcoming about the health risks associated with the implant and the surgery,” said Amber Mostyn.
Mostyn Law is among the nation’s leaders in bringing cases forward related to the damages caused by vaginal mesh implants. The Houston-based law firm’s cases, including its major civil suit, Teresa Stevens v. Boston Scientific, seek damages from Boston Scientific on behalf of women who are victims of allegedly counterfeit resin mesh implants. In the case of Teresa Stevens, Mostyn Law has filed a federal racketeering class action lawsuit against Boston Scientific. This is the first RICO lawsuit filed in transvaginal mesh litigation.
“I admire Attorneys General Bob Ferguson and Kamala Harris’ actions. At Mostyn Law, Amber, our entire team and I are committed to helping the victims of these implants and to making sure no else suffers from the problems of vaginal mesh implants,” said Steve Mostyn.
6 comments. Leave new
[…] a slew of companies including Bard and Boston Scientific are currently in progress, with firms like Mostyn Law charging the way. Though it’s unclear yet how much settlement money mesh lawsuits will eventually […]
[…] mesh manufacturers, that predicted a multimillion dollar industry from creating pelvic mesh to treat POP, often refer to it in the literature as a disease” that […]
[…] is the case of transvaginal mesh, manufactured by conglomerates like Boston Scientific and Johnson & Johnson. The vast majority of modern transvaginal mesh implants came onto the market through the 510(k) […]
[…] linked, they were predicated on some other devices that were based on ProteGen. Mentor, Ethicon, American Medical Systems, Gyne Ideas, Tyco, Caldera all either named ProteGen as their direct or […]
[…] because there is indisputable evidence that the mesh manufacturers – Boston Scientific, Johnson & Johnson, AMS, CR Bard and the others – knew in advance that their mesh would have problems and they […]
[…] Dr. Anne Weber authored the ACOG bulletin and she intentionally used the word “experimental” in describing mesh to do pelvic surgery. […]